A novel polymorphism, E254K, in the 5-lipoxygenase gene associated with bronchial asthma

International Journal of Molecular Medicine

Volumn 21, Issue 2, 2008, Pages 139-144

  Bai, Chunying ^a   Matsui, Eiko ^a   Ohnishi, Hidenori ^a   Kimata, Kaori ^a   Kasahara, Kimiko ^a   Kaneko, Hideo ^a   Kato, Zenichiro ^a   Fukao, Toshiyuki ^a   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

5 lipoxygenase gene; Bronchial asthma; Leukotrienes; Single nucleotide polymorphism

Indexed keywords

ADENINE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; GLUTAMIC ACID; GUANINE; LYSINE; PEPTIDOLEUKOTRIENE;

AMINO ACID SUBSTITUTION; ARTICLE; ASTHMA; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EXON; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 38949111003     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.2.139     Document Type: Article

References (26)

1. Bochner BS and Busse WW: Allergy and asthma. J Allergy Clin Immunol 115: 953-959, 2005.
2. Sanak M: Genetic variance of 5-lipoxygenase metabolic pathway in bronchial asthma. Int Rev Asthma 4: 70-80, 2002.
3. Chen XS, Sheller JR, Johnson EN and Funk CD: Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372: 179-182, 1994.
4. Samuelsson B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568-575, 1983.
5. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA and Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1237: 1171-1176, 1987.
6. Lewis RA, Austen KF and Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323: 645-655, 1990.
7. Funk CD, Hoshiko S, Matsumoto T, Radmark O and Samuelsson B: Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci USA 86: 2587-2591, 1989.
8. Drazen JM and Silverman ES: Genetic determinants of 5-lipoxygenase transcription. Int Arch Allergy Immunol 118: 275-278, 1999.
9. Silverman ES and Drazen JM: Genetic variations in the 5-lipoxygenase core promoter. Am J Respir Crit Care Med 161: 77-80, 2000.
10. Koshino T, Takano S, Kitani S, et al: Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma. Mol Cell Biol Res Commun 2: 32-35, 1999.
11. Koshino T, Takano S, Houjo T, et al: Expression of 5-lipoxygenase (5-LO) and 5-lipoxygenase-activating protein (FLAP) mRNAs in the peripheral blood leukocytes of asthma. Biochem Biophys Res Commun 247: 510-513, 1998.
12. Helgadottir A, Manolescu A, Thorleifssort G, et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36: 233-239, 2004.
13. ΔΔCt method. Methods 25: 402-408, 2001.
14. Caterina RD and Zampolli A: From asthma to atherosclerosis - 5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 350: 4-7, 2004.
15. Shibata A, Katsunuma T, Tomikawa M, Tan A, Yuki K, Akashi K and Eto Y: Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 130: 1718-1722, 2006.
16. In K-H, Silverman ES, Asano K, et al: Mutations in the human 5-lipoxygenase gene. Clin Rev Allergy Immunol 17: 59-69, 1999.
17. Yuen PH, Ryan EA, Devroe E and Wong PKY: A single Glu (62)-to-Lys (62) mutation in the Mos residues of the R7Delta447Gag-tMos protein causes the mutant virus to induce brain lesions. Oncogene 20: 692-703, 2001.
18. Berretta F, Butler RH, Diaz G, et al: Detailed analysis of the effects of Glu/Lys 669 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens 62: 459-471, 2003.
19. Provost P, Samuelsson B and Radmark O: Interaction of 5-lipoxygenase with cellular proteins. Biochemistry 96: 1881-1885, 1999.
20. Manev H and Tolga UZ: Primary cultures of rat cerebellar granule cells as a model to study neuronal 5-lipoxygenase and FLAP gene expression. Ann NY Acad Sci 890: 183-190, 1999.
21. Zimmer JS, Dyckes DF, Bernlohr DA and Murphy RC: Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res 45: 2138-2144, 2004.
22. Voelkel NF, Tuder RM, Wade K, et al: Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest 97: 2491-2498, 1996.
23. Lepley RA, Muskardin DT and Fitzpatrick FA: Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J Biol Chem 271: 6179-6184, 1996.
24. Abramovitz M, Wong E, Cox ME, Richardson CD, Li C and Vickers PJ: 5 -Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 215: 105-111, 1993.
25. In KH, Asano K, Beier D, et al: Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 99: 1130-1137, 1997.
26. Israel E: Genetics and the variability of treatment response in asthma. J Allergy Clin Immunol 115: 532-538, 2005.